Supply Chain

Basel, Switzerland-based Novartis on Monday signed a licensing agreement with Conatus Pharmaceuticals to co-develop a fatty liver disease drug, reports Reuters.

When dieting, individuals must consider not only how much they eat, but also what type of food they should consume to shed pounds. Similarly, when health systems attempt to reduce supply chain costs, they should consider both the volume of…

Tens of millions of Americans have purchased prescription drugs from outside of the U.S. and imported them into the country, reports Kaiser Health News.

The holiday season is perhaps the busiest time of year for the retail sector. Between Black Friday, Cyber Monday and many well-timed new product launches, we can assume that the supply chain is working overtime.

Bob Kocher, MD, and Bryan Roberts are partners at the venture capital firm Venrock, where they specialize in healthcare-related investment opportunities. In an article for Fortune, Dr. Kocher and Mr. Roberts share 10 healthcare predictions for 2017.

Clovis Oncology on Monday earned accelerated approval from the Food and Drug Administration for its ovarian cancer drug Rubracam, reports Reuters.

The U.K.'s National Institute for Health and Care Excellence will join the Food and Drug Administration's Payer Communication Task Force to help more medical devices, diagnostics and other health-related technologies reach the market faster, reports RAPS.

Mondher Mahjoubi will leave his role as head of AstraZeneca's oncology division to serve as the new CEO of Innate Pharma, a French biotech focusing on immuno-oncology therapies, reports Reuters.

Amazon may be developing — or looking to acquire — a mobile technology to link available trucks with shipments needing to be transported, reports The Wall Street Journal.

As drug prices continue to rise, many U.S. hospitals are implementing aggressive strategies to reduce pharmaceutical spending, reports The Wall Street Journal.